Opinion

German pharma antitrust in 40 questions - a practitioner's guide

Published Date
Jul 28, 2022
Our Hamburg-based German antitrust team has contributed a chapter on Germany to Lexology Get The Deal Through’s global report on Pharmaceutical Antitrust. 
In their contribution, they provide guidance on the regulatory framework, merger control aspects and potential enforcement risks with regard to anticompetitive agreements as well as anticompetitive unilateral conduct for those active in the German pharmaceutical sector.

Content Disclaimer
This content was originally published by Allen & Overy before the A&O Shearman merger

Related capabilities

AntitrustAntitrust and intellectual propertyDisputesLife sciences and healthcarePharmaceuticals

About the
authors

Image

Dr Ellen Braun

Partner

Hamburg

She has an active practice representing clients in competition proceedings before the EU Commission, the German Federal Cartel Offic...

No image available

Philipp Steinhaeuser

Associate

Hamburg

He holds doctorate in competition law and was a scholar of the »Arbeitskreis Wirtschaft und Recht« during his doctorate stu...